A detailed history of D. E. Shaw & Co., Inc. transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 368,680 shares of ITCI stock, worth $31.4 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
368,680
Holding current value
$31.4 Million
% of portfolio
0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$67.99 - $80.84 $14.4 Million - $17.1 Million
-211,679 Reduced 36.47%
368,680 $27 Million
Q2 2024

Aug 14, 2024

BUY
$64.76 - $79.84 $12.3 Million - $15.2 Million
190,080 Added 48.7%
580,359 $39.7 Million
Q1 2024

May 15, 2024

SELL
$64.37 - $75.65 $7.81 Million - $9.17 Million
-121,271 Reduced 23.71%
390,279 $27 Million
Q4 2023

Feb 14, 2024

SELL
$46.37 - $73.65 $10.7 Million - $16.9 Million
-229,827 Reduced 31.0%
511,550 $36.6 Million
Q3 2023

Nov 14, 2023

SELL
$52.09 - $64.1 $11 Million - $13.6 Million
-211,465 Reduced 22.19%
741,377 $38.6 Million
Q2 2023

Aug 14, 2023

BUY
$54.67 - $66.44 $24.2 Million - $29.4 Million
442,938 Added 86.87%
952,842 $60.3 Million
Q1 2023

May 15, 2023

SELL
$43.8 - $56.99 $157,504 - $204,936
-3,596 Reduced 0.7%
509,904 $27.6 Million
Q4 2022

Feb 14, 2023

BUY
$44.07 - $54.45 $7.2 Million - $8.9 Million
163,422 Added 46.68%
513,500 $27.2 Million
Q3 2022

Nov 14, 2022

BUY
$42.7 - $59.99 $487,505 - $684,905
11,417 Added 3.37%
350,078 $16.3 Million
Q2 2022

Aug 15, 2022

SELL
$43.0 - $65.64 $1.12 Million - $1.7 Million
-25,957 Reduced 7.12%
338,661 $19.3 Million
Q1 2022

May 16, 2022

BUY
$38.74 - $62.09 $8.18 Million - $13.1 Million
211,031 Added 137.4%
364,618 $22.3 Million
Q4 2021

Feb 14, 2022

BUY
$35.2 - $53.42 $5.41 Million - $8.2 Million
153,587 New
153,587 $8.04 Million
Q3 2021

Nov 15, 2021

SELL
$28.72 - $42.49 $1.38 Million - $2.04 Million
-48,063 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$29.3 - $44.5 $2.11 Million - $3.2 Million
-71,936 Reduced 59.95%
48,063 $1.96 Million
Q1 2021

May 17, 2021

BUY
$30.8 - $39.51 $680,556 - $873,012
22,096 Added 22.57%
119,999 $4.07 Million
Q4 2020

Feb 16, 2021

SELL
$23.34 - $32.22 $3.07 Million - $4.24 Million
-131,700 Reduced 57.36%
97,903 $3.11 Million
Q3 2020

Nov 16, 2020

BUY
$17.61 - $31.86 $854,401 - $1.55 Million
48,518 Added 26.79%
229,603 $5.89 Million
Q2 2020

Aug 14, 2020

SELL
$14.35 - $26.64 $76,944 - $142,843
-5,362 Reduced 2.88%
181,085 $4.65 Million
Q1 2020

May 15, 2020

SELL
$12.31 - $33.12 $553,531 - $1.49 Million
-44,966 Reduced 19.43%
186,447 $2.87 Million
Q4 2019

Feb 14, 2020

BUY
$7.26 - $38.49 $13,699 - $72,630
1,887 Added 0.82%
231,413 $7.94 Million
Q3 2019

Nov 14, 2019

SELL
$7.47 - $14.03 $936,454 - $1.76 Million
-125,362 Reduced 35.32%
229,526 $1.71 Million
Q2 2019

Aug 14, 2019

BUY
$10.65 - $14.29 $454,009 - $609,182
42,630 Added 13.65%
354,888 $4.61 Million
Q1 2019

May 15, 2019

BUY
$10.9 - $14.09 $977,588 - $1.26 Million
89,687 Added 40.3%
312,258 $3.8 Million
Q4 2018

Feb 14, 2019

BUY
$10.36 - $20.96 $287,572 - $581,807
27,758 Added 14.25%
222,571 $2.54 Million
Q3 2018

Nov 14, 2018

BUY
$17.77 - $22.9 $208,673 - $268,914
11,743 Added 6.41%
194,813 $4.23 Million
Q2 2018

Aug 14, 2018

SELL
$17.33 - $23.4 $684,552 - $924,323
-39,501 Reduced 17.75%
183,070 $3.24 Million
Q1 2018

May 15, 2018

BUY
$15.16 - $25.49 $2.8 Million - $4.7 Million
184,416 Added 483.33%
222,571 $4.69 Million
Q4 2017

Feb 14, 2018

BUY
$14.27 - $16.79 $544,471 - $640,622
38,155
38,155 $552,000

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.05B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.